GFACX
Price
$70.96
Change
+$0.29 (+0.41%)
Updated
Jul 16 closing price
Net Assets
322.72B
JFRDX
Price
$56.29
Change
+$0.21 (+0.37%)
Updated
Jul 16 closing price
Net Assets
23.07B
Interact to see
Advertisement

GFACX vs JFRDX

Header iconGFACX vs JFRDX Comparison
Open Charts GFACX vs JFRDXBanner chart's image
American Funds Growth Fund of Amer C
Price$70.96
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets322.72B
Janus Henderson Forty D
Price$56.29
Change+$0.21 (+0.37%)
VolumeN/A
Net Assets23.07B
GFACX vs JFRDX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. JFRDX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and JFRDX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 323B vs. JFRDX (23.1B). JFRDX pays higher dividends than GFACX: JFRDX (0.11) vs GFACX (0.00). GFACX was incepted earlier than JFRDX: GFACX (24 years) vs JFRDX (8 years). GFACX (1.36) is less costly to investors than JFRDX (0.63). JFRDX is a more actively managed with annual turnover of: 36.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than JFRDX: GFACX (250) vs JFRDX (2500). GFACX annual gain was more profitable for investors over the last year : 7.11 vs. JFRDX (4.20). GFACX (35.91) and JFRDX (34.88) have equivalent 5 years return.
GFACXJFRDXGFACX / JFRDX
Total Expense Ratio1.360.63216%
Annual Report Gross Expense Ratio1.360.63216%
Fund Existence24 years8 years-
Gain YTD11.29210.372109%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets323B23.1B1,398%
Annual Yield % from dividends0.000.11-
Returns for 1 year7.114.20169%
Returns for 3 years52.0160.6286%
Returns for 5 years35.9134.88103%
Returns for 10 years63.31N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT1.860.06
+3.33%
Inhibikase Therapeutics
MKC71.380.63
+0.89%
McCormick & Company
VTS22.940.06
+0.26%
Vitesse Energy
ADN1.95N/A
N/A
Advent Technologies Holdings Inc.
BTE1.84-0.04
-2.13%
Baytex Energy Corp